{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:45:37Z","timestamp":1773827137036,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijantimicag.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T20:15:55Z","timestamp":1498680955000},"page":"491-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan"],"prefix":"10.1016","volume":"50","author":[{"given":"Jung-Yien","family":"Chien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrurol.2011.172","article-title":"Medscape. Etiology and management of genitourinary tuberculosis","volume":"8","author":"Abbara","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0015","first-page":"217","article-title":"Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis","volume":"14","author":"Webster","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkm061","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure","volume":"59","author":"Wang","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0030","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1128\/AAC.01049-15","article-title":"Mutations in gyrA and gyrB among fluoroquinolone- and multidrug-resistant Mycobacterium tuberculosis isolates","volume":"60","author":"Chien","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0035","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JCM.05286-11","article-title":"High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility","volume":"50","author":"Devasia","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1073\/pnas.93.1.362","article-title":"Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis","volume":"93","author":"Takiff","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0045","first-page":"535","article-title":"Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates","volume":"133","author":"Singh","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0050","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/AAC.02293-13","article-title":"Energy metabolism and drug efflux in Mycobacterium tuberculosis","volume":"58","author":"Black","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0055","article-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0060","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1128\/AAC.00425-16","article-title":"Moxifloxacin improves treatment outcomes in patients with ofloxacin-resistant multidrug-resistant tuberculosis","volume":"60","author":"Chien","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.201011-1924OC","article-title":"Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux","volume":"184","author":"Louw","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0070","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"Schmalstieg","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0075","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1261307","article-title":"Tuberculosis and the kidney","volume":"12","author":"Eastwood","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/mdr.2013.0171","article-title":"Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype","volume":"20","author":"Sun","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000109769","article-title":"Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid","volume":"53","author":"Escribano","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0100","doi-asserted-by":"crossref","first-page":"e34538","DOI":"10.1371\/journal.pone.0034538","article-title":"Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis","volume":"7","author":"Machado","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.04.010_bib0105","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.05693-11","article-title":"Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli","volume":"56","author":"Singh","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T06:05:39Z","timestamp":1750399539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0924857917302078"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}